Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markman

Showing results (371-380 of 545) with videos related to

Pageof 55
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
A phase I trial of intraperitoneal recombinant gamma-interferon in advanced ovarian carcinomaR D'Acquisto, M Markman, T Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group StudyM Markman, M F Brady, N M Spirtos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Clinical features of hypersensitivity reactions to carboplatinM Markman, A Kennedy, K Webster, et al.
Gynecologic Oncology|March 31, 2000
Phase II evaluation of 24-h continuous infusion topotecan in recurrent, potentially platinum-sensitive ovarian cancer: A Gynecologic Oncology Group studyM Markman, J A Blessing, R D Alvarez, et al.
Gynecologic Oncology|July 1, 1999
Survival probability in ovarian clear cell adenocarcinomaA W Kennedy, M Markman, C V Biscotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavityM Markman, S B Howell, W E Lucas, et al.
JAMA|December 10, 1982
Sulfamethoxazole-trimethoprim-resistant pneumococcal sepsisM Markman, J Mannisi, J D Dick, et al.
Gynecologic Oncology|July 27, 1999
The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinomaK M Zanotti, J L Belinson, A W Kennedy, et al.
Hepatology (Baltimore, Md.)|February 10, 2004
Stereological measurement of porto-central gradients in gene expression in mouse liverJan M Ruijter, Roben G Gieling, Marry M Markman, et al.
Gynecologic Oncology|November 7, 2000
Treatment of relapsed carcinoma of the ovary with single-agent paclitaxel following exposure to paclitaxel and platinum employed as initial therapyK M Zanotti, J L Belinson, A W Kennedy, et al.
Pageof 55

Showing results (371-380 of 545) with videos related to

Sort By:
Pageof 55
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
A phase I trial of intraperitoneal recombinant gamma-interferon in advanced ovarian carcinomaR D'Acquisto, M Markman, T Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group StudyM Markman, M F Brady, N M Spirtos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Clinical features of hypersensitivity reactions to carboplatinM Markman, A Kennedy, K Webster, et al.
Gynecologic Oncology|March 31, 2000
Phase II evaluation of 24-h continuous infusion topotecan in recurrent, potentially platinum-sensitive ovarian cancer: A Gynecologic Oncology Group studyM Markman, J A Blessing, R D Alvarez, et al.
Gynecologic Oncology|July 1, 1999
Survival probability in ovarian clear cell adenocarcinomaA W Kennedy, M Markman, C V Biscotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavityM Markman, S B Howell, W E Lucas, et al.
JAMA|December 10, 1982
Sulfamethoxazole-trimethoprim-resistant pneumococcal sepsisM Markman, J Mannisi, J D Dick, et al.
Gynecologic Oncology|July 27, 1999
The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinomaK M Zanotti, J L Belinson, A W Kennedy, et al.
Hepatology (Baltimore, Md.)|February 10, 2004
Stereological measurement of porto-central gradients in gene expression in mouse liverJan M Ruijter, Roben G Gieling, Marry M Markman, et al.
Gynecologic Oncology|November 7, 2000
Treatment of relapsed carcinoma of the ovary with single-agent paclitaxel following exposure to paclitaxel and platinum employed as initial therapyK M Zanotti, J L Belinson, A W Kennedy, et al.
Pageof 55